REGN Regeneron Pharmaceuticals

held by 1 manager in Q2 2020

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.74%	3 mo	NEW	$24M	38,700

Search